Lin Gen-Min, Liu Kiang, Colangelo Laura A, Lakoski Susan G, Tracy Russell P, Greenland Philip
Am J Epidemiol. 2016 Jan 1;183(1):46-52. doi: 10.1093/aje/kwv144. Epub 2015 Nov 22.
High-sensitivity C-reactive protein (hs-CRP) has been associated with coronary heart disease (CHD) in numerous but not all observational studies, and whether low levels of low-density lipoprotein cholesterol (LDL-C) alter this association is unknown. In the Multi-Ethnic Study of Atherosclerosis (2000-2012), we prospectively assessed the association of hs-CRP concentrations with incident CHD in participants who did not receive lipid-lowering therapy, as well as in those with LDL-C concentrations less than 130 mg/dL (n = 3,106) and those with LDL-C concentrations of 130 mg/dL or greater (n = 1,716) at baseline (2000-2002). Cox proportional hazard analyses were used to assess the associations after adjustment for socioeconomic status, traditional risk factors, body mass index, diabetes, aspirin use, kidney function, and coronary artery calcium score. Loge hs-CRP was associated with incident CHD in participants with LDL-C concentrations of 130 mg/dL or higher (hazard ratio (HR) = 1.29, 95% confidence interval (CI): 1.05, 1.60) but not in those with LDL-C concentrations less than 130 mg/dL (HR = 0.88, 95% CI: 0.74, 1.05; P for interaction = 0.003). As a whole, loge hs-CRP was not associated with incident CHD in participants who had not received lipid-lowering therapy at baseline (HR = 1.05, 95% CI: 0.92, 1.20) and who had mean LDL-C concentrations less than 130 mg/dL. These findings suggest that LDL-C concentrations might be a moderator of the contribution of hs-CRP to CHD.
在众多但并非所有的观察性研究中,高敏C反应蛋白(hs-CRP)都与冠心病(CHD)相关,而低密度脂蛋白胆固醇(LDL-C)水平较低是否会改变这种关联尚不清楚。在动脉粥样硬化多民族研究(2000 - 2012年)中,我们前瞻性地评估了hs-CRP浓度与未接受降脂治疗的参与者发生冠心病的关联,以及基线时(2000 - 2002年)LDL-C浓度低于130mg/dL(n = 3106)和LDL-C浓度为130mg/dL或更高(n = 1716)的参与者发生冠心病的关联。采用Cox比例风险分析评估在调整社会经济地位、传统危险因素、体重指数、糖尿病、阿司匹林使用情况、肾功能和冠状动脉钙化评分后的关联。Loge hs-CRP与LDL-C浓度为130mg/dL或更高的参与者发生冠心病相关(风险比(HR)= 1.29,95%置信区间(CI):1.05,1.60),但与LDL-C浓度低于130mg/dL的参与者无关(HR = 0.88,95%CI:0.74,1.05;交互作用P值 = 0.003)。总体而言,Loge hs-CRP与基线时未接受降脂治疗且平均LDL-C浓度低于130mg/dL的参与者发生冠心病无关(HR = 1.05,95%CI:0.92,1.20)。这些发现表明,LDL-C浓度可能是hs-CRP对冠心病影响的一个调节因素。